Literature DB >> 21940904

Analysis and prediction of drug transfer into human milk taking into consideration secretion and reuptake clearances across the mammary epithelia.

Hiroki Koshimichi1, Kousei Ito, Akihiro Hisaka, Masashi Honma, Hiroshi Suzuki.   

Abstract

Medication use during lactation is a matter of concern due to unnecessary exposure of infants to drugs. Although some studies have predicted the extent of drug transfer into milk from physicochemical parameters, drug concentration-time profiles in milk have not been predicted or even analyzed yet. In the present study, a drug transfer model was constructed by defining secretion and reuptake clearances (CL(sec) and CL(re), respectively) between milk and plasma based on unbound drug concentrations. Through the use of this model, drug concentration-time profiles were analyzed in human milk and plasma based on data collected from the literature. CL(sec) and CL(re) values were obtained successfully for 49 drugs. Because the CL(sec) and CL(re) values were in general similar for each drug, transport across the mammary epithelia was mediated by passive diffusion in most cases. This study demonstrated that the logarithmically transformed values of CL(sec) and CL(re) can be predicted from physicochemical parameters with adjusted R(2) values of 0.705 and 0.472, respectively. Moreover, 66.7 and 77.8% of predicted CL(sec) and CL(re) values were within 3-fold error ranges of the observed values for 45 and 27 drugs, respectively. Finally, time profiles of drug concentrations in milk were simulated from physicochemical parameters. The milk-to-plasma area under the concentration-time curve ratios also were predicted successfully within 3-fold error ranges of the observed values for 71.9% of the drugs analyzed. The method described herein therefore may be useful in predicting drug concentration-time profiles in human milk for newly developed drugs.

Entities:  

Mesh:

Year:  2011        PMID: 21940904     DOI: 10.1124/dmd.111.040972

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

Review 1.  Drugs in Lactation.

Authors:  Philip O Anderson
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

2.  Prediction of Drug Transfer into Milk Considering Breast Cancer Resistance Protein (BCRP)-Mediated Transport.

Authors:  Naoki Ito; Kousei Ito; Yuki Ikebuchi; Yu Toyoda; Tappei Takada; Akihiro Hisaka; Akira Oka; Hiroshi Suzuki
Journal:  Pharm Res       Date:  2015-02-19       Impact factor: 4.200

3.  An in vitro human mammary epithelial cell permeability assay to assess drug secretion into breast milk.

Authors:  Tao Zhang; Zachary Applebee; Peng Zou; Zhen Wang; Erika Solano Diaz; Yanyan Li
Journal:  Int J Pharm X       Date:  2022-06-22

4.  Tacrolimus placental transfer at delivery and neonatal exposure through breast milk.

Authors:  Songmao Zheng; Thomas R Easterling; Karen Hays; Jason G Umans; Menachem Miodovnik; Shannon Clark; Justina C Calamia; Kenneth E Thummel; Danny D Shen; Connie L Davis; Mary F Hebert
Journal:  Br J Clin Pharmacol       Date:  2013-12       Impact factor: 4.335

5.  Contribution of protein binding, lipid partitioning, and asymmetrical transport to drug transfer into milk in mouse versus human.

Authors:  Naoki Ito; Kousei Ito; Hiroki Koshimichi; Akihiro Hisaka; Masashi Honma; Takashi Igarashi; Hiroshi Suzuki
Journal:  Pharm Res       Date:  2013-05-31       Impact factor: 4.200

6.  Development of an in vitro cell culture model to study milk to plasma ratios of therapeutic drugs.

Authors:  Maithili A Athavale; Anurupa Maitra; Shahnaz Patel; Vijay R Bhate; Villi S Toddywalla
Journal:  Indian J Pharmacol       Date:  2013 Jul-Aug       Impact factor: 1.200

7.  Prediction of drug concentrations in milk during breastfeeding, integrating predictive algorithms within a physiologically-based pharmacokinetic model.

Authors:  Khaled Abduljalil; Amita Pansari; Jia Ning; Masoud Jamei
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.